Spots Global Cancer Trial Database for karenitecin
Every month we try and update this database with for karenitecin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian Cancer | NCT00477282 | Ovarian Cancer | Karenitecin Topotecan | 18 Years - | BioNumerik Pharmaceuticals, Inc. | |
Karenitecin in Treating Patients With Recurrent Malignant Glioma | NCT00014521 | Brain and Centr... | karenitecin | 18 Years - | National Cancer Institute (NCI) | |
Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma | NCT00358319 | Malignant Melan... | Karenitecin Valproic Acid | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute |